Get started
Author

Sai Lahari Sangaraju

Fibromyalgia and Depression: A Literature Review of Their Shared Aspects
2022 · Daniela Yepez, Xavier A Grandes, et al. · Cureus · 66
PDF
Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review
2022 · Sai Lahari Sangaraju, Daniela Yepez, et al. · Cureus · 64
PDF
Multiple Sclerosis: Therapeutic Strategies on the Horizon
2022 · Ramya Talanki Manjunatha, Salma Habib, et al. · Cureus · 36
PDF
The Nexus Between Diabetes and Depression: A Narrative Review
2022 · Salma Habib, Sai Lahari Sangaraju, et al. · Cureus · 33
PDF
Gastroesophageal Reflux Disease and Asthma: A Narrative Review
2022 · Xavier A Grandes, Ramya Talanki Manjunatha, et al. · Cureus · 19
PDF
Cardiovascular Complications in Hemoglobinopathies: Pathophysiology, Clinical Spectrum, and Management
2026 · Daniel Bradach, Karla Calderon Salavarria, et al. · European Journal Of Haematology · 2
Clinical Presentation and Pattern of Cardiac Involvement in Patients with Rheumatic Heart Disease: A Prospective Observational Study
2023 · M. Arjun, D. Rajasekhar, et al. · Journal of the Practice of Cardiovascular Sciences · 1
CT-1048: Early Mortality Following CAR-T Therapy in Hematologic Malignancies: A Population-Level Study
2026 · Nanditha Karra, Harshal Chorya, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-1608: Age-Stratified Survival Trends in Acute Myeloid Leukemia Before and After Venetoclax Adoption: A Comprehensive Population-Level and Real-World Analysis
2026 · Sai Mourya Meda, Harshal Chorya, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-971: MRD-Adjusted Therapeutic Index of Menin Inhibitors in NPM1-Mutated and KMT2A-Rearranged Acute Myeloid Leukemia: A Genotype-Stratified Systematic Review and Meta-Analysis
2026 · Sai Mourya Meda, Sai Lahari Sangaraju, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1458: Infection-Fatality Phenotype of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Target-Stratified Systematic Review and Meta-Analysis
2026 · Gowrishankar Palaniswamy, Nanditha Karra, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: CML-547: Impact of Posterior Reversible Encephalopathy Syndrome on Hospitalization and Mortality in Tyrosine Kinase Inhibitor–Treated Patients With Hematologic Malignancies: A Real-World Propensity-Matched Analysis
2026 · Katherin Zambrano-Vera, Antonio Arciniegas Rubio, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1458: Infection-Fatality Phenotype of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Target-Stratified Systematic Review and Meta-Analysis
2026 · Gowrishankar Palaniswamy, Nanditha Karra, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-995: Development of the Bispecific Outpatient Readiness Score: An Institutional Readiness Tool for Outpatient Bispecific Antibody Therapy in Multiple Myeloma
2026 · Sweta Sahu, Harshal Chorya, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-968: Residual Excess Mortality During the COVID-19 Era in Multiple Myeloma and Related Plasma Cell Neoplasms: A CDC WONDER Counterfactual Predictive Analysis
2026 · Nanditha Karra, Thanuja Mora, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-1124: Real-World Utilization Trends and Access Disparities in CAR-T Therapy Across the Globe
2026 · Harshal Chorya, Sweta Sahu, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1606: The Age-Race Paradox in Multiple Myeloma: Younger Diagnosis but Persistent Early Mortality Among Black Patients in the United States
2026 · Sai Lahari Sangaraju, Thanuja Mora, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-995: Development of the Bispecific Outpatient Readiness Score: An Institutional Readiness Tool for Outpatient Bispecific Antibody Therapy in Multiple Myeloma
2026 · Sweta Sahu, Harshal Chorya, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1637: Environmental Double Burden in Multiple Myeloma: PM2.5 Exposure and Racial Outcome Disparities Among Non-Hispanic Black and White Patients in the United States
2026 · Sweta Sahu, Harshal Chorya, et al. · Clinical Lymphoma Myeloma & Leukemia
CML-547: Impact of Posterior Reversible Encephalopathy Syndrome on Hospitalization and Mortality in Tyrosine Kinase Inhibitor-Treated Patients With Hematologic Malignancies: A Real-World Propensity-Matched Analysis
2026 · Katherin Zambrano-Vera, Antonio Arciniegas Rubio, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1606: The Age-Race Paradox in Multiple Myeloma: Younger Diagnosis but Persistent Early Mortality Among Black Patients in the United States
2026 · Sai Lahari Sangaraju, Thanuja Mora, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-971: MRD-Adjusted Therapeutic Index of Menin Inhibitors in NPM1-Mutated and KMT2A- Rearranged Acute Myeloid Leukemia: A Genotype-Stratified Systematic Review and Meta-Analysis
2026 · Sai Mourya Meda, Sai Lahari Sangaraju, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-1048: Early Mortality Following CAR-T Therapy in Hematologic Malignancies: A Population-Level Study
2026 · Nanditha Karra, Harshal Chorya, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-968: Residual Excess Mortality During the COVID-19 Era in Multiple Myeloma and Related Plasma Cell Neoplasms: A CDC WONDER Counterfactual Predictive Analysis
2026 · Nanditha Karra, Thanuja Mora, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-1608: Age-Stratified Survival Trends in Acute Myeloid Leukemia Before and After Venetoclax Adoption: A Comprehensive Population-Level and Real-World Analysis
2026 · Sai Mourya Meda, Harshal Chorya, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 39
Citation count: 221
H-index: 5
I10-index: 5
Year
Topic
Type